Jaypirca (pirtobrutinib tablets) — Cigna

Initial criteria

• Patient age ≥ 18 years AND
• Patient has tried at least one systemic regimen that includes one or more of the following: Brukinsa (zanubrutinib), Imbruvica (ibrutinib), rituximab, bendamustine, cyclophosphamide, dexamethasone, bortezomib, Kyprolis (carfilzomib), or Ninlaro (ixazomib)

Approval duration

1 year